Literature DB >> 29281120

Iron Supplementation-Induced Phosphaturic Osteomalacia: FGF23 is the Culprit.

Tomas Urbina1,2, Rakiba Belkhir1,2, Geoffrey Rossi1,2, Franck Carbonnel1, Stephan Pavy1,2, Michael Collins1, Xavier Mariette1,2, Raphaèle Seror1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29281120     DOI： 10.1002/jbmr.3369

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  11 in total

1.  Randomized trial of intravenous iron-induced hypophosphatemia.

Authors:  Myles Wolf; Glenn M Chertow; Iain C Macdougall; Robert Kaper; Julie Krop; William Strauss
Journal:  JCI Insight       Date:  2018-12-06

Review 2.  Crosstalk between fibroblast growth factor 23, iron, erythropoietin, and inflammation in kidney disease.

Authors:  Jodie L Babitt; Despina Sitara
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-07       Impact factor: 2.894

Review 3.  Regulation of FGF23: Beyond Bone.

Authors:  Petra Simic; Jodie L Babitt
Journal:  Curr Osteoporos Rep       Date:  2021-11-10       Impact factor: 5.096

4.  Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency.

Authors:  Rebecca Frazier; Alexander Hodakowski; Xuan Cai; Jungwha Lee; Anaadriana Zakarija; Brady Stein; Valentin David; Myles Wolf; Tamara Isakova; Rupal Mehta
Journal:  Bone       Date:  2020-07-28       Impact factor: 4.398

5.  Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron-Deficient Patients With Autosomal Dominant Hypophosphatemic Rickets.

Authors:  Erik A Imel; Ziyue Liu; Melissa Coffman; Dena Acton; Rakesh Mehta; Michael J Econs
Journal:  J Bone Miner Res       Date:  2019-10-25       Impact factor: 6.741

6.  Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF.

Authors:  Jonathan A Wheeler; Erica L Clinkenbeard
Journal:  Curr Mol Biol Rep       Date:  2019-01-25

Review 7.  Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome.

Authors:  John A Glaspy; Myles Wolf; William E Strauss
Journal:  Adv Ther       Date:  2021-05-30       Impact factor: 3.845

Review 8.  Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review.

Authors:  John A Glaspy; Michelle Z Lim-Watson; Michael A Libre; Swagata S Karkare; Nandini Hadker; Aleksandra Bajic-Lucas; William E Strauss; Naomi V Dahl
Journal:  Ther Clin Risk Manag       Date:  2020-04-08       Impact factor: 2.423

9.  Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact.

Authors:  Trond Espen Detlie; Jonas Christoffer Lindstrøm; Marte Eide Jahnsen; Elisabeth Finnes; Heinz Zoller; Bjørn Moum; Jørgen Jahnsen
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

10.  A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose.

Authors:  Giuseppe Rosano; Ingolf Schiefke; Udo-Michael Göhring; Vincent Fabien; Stefano Bonassi; Jürgen Stein
Journal:  J Clin Med       Date:  2020-11-06       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.